Beijing Tongrentang Co., Ltd (SHA: 600085)

Market Cap	56.37B
Revenue (ttm)	17.96B
Net Income (ttm)	1.63B
Shares Out	1.37B
EPS (ttm)	1.19
PE Ratio	34.62
Forward PE	39.90
Dividend	0.50 (1.21%)
Ex-Dividend Date	Oct 10, 2024

Volume	11,463,940
Open	41.29
Previous Close	41.01
Day's Range	40.82 - 42.17
52-Week Range	30.84 - 55.74
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally. The company provides product formulations, such as pills, powders, liquors, capsules, oral liquids, and dripping pills in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, tonic and soothe the nerves, digestive system, pediatrics, expelling wind and dampness, orthopedics, five senses, skin surgery, spiritual, and food alcohol diseases. It sells its products under t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 16,777
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2023, Beijing Tongrentang's revenue was 17.86 billion, an increase of 16.19% compared to the previous year's 15.37 billion. Earnings were 1.67 billion, an increase of 16.92%.